Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/animal-models-of-parkinson-s-disease-an-empirical-comparison-with-the-yn6bBZ6h6b
References (293)
-
M. Jarvis, G. Wagner (1985)
Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamine.Life sciences, 36 3
-
G. Ricaurte, R. Guillery, L. Seiden, C. Schuster, R. Moore, R. Moore (1982)
Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brainBrain Research, 235
-
P. Riederer, S. Wuketich (1976)
Time course of nigrostriatal degeneration in parkinson's diseaseJournal of Neural Transmission, 38
-
MJ Zigmond, EM Stricker (1989)
International review of neurobiology, vol 31 -
W Haefely (1978)
Langzeitbehandlung des Parkinson-Syndroms -
S Hall, JH Rulledge, T Schallert (1992)
MRI brain iron and 6-hydroxydopamine experimental Parkinson's diseaseJ Neurol Sci, 113
-
M. Naoi, W. Maruyama, J. Zhang, T. Takahashi, Y. Deng, P. Dostert (1995)
Enzymatic oxidation of the dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion.Life sciences, 57 11
-
G Dordain, P Dostert, M Strolin-Benedetti, V Rovei (1984)
Monoamine oxidase and disease. Prospects for therapy with reversible inhibitors -
B. Janetzky, R. God, G. Bringmann, H. Reichmann (1995)
1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I.Journal of neural transmission. Supplementum, 46
-
Tetsuya Tsukahara, Makoto Takeda, Shun Shimohama, Osamu Ohara, Nobuo Hashimoto (1995)
Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys.Neurosurgery, 37 4
-
P. Riederer, E. Sofić, W. Rausch, G. Hebenstreit, J. Bruinvels (1989)
Pathobiochemistry of the extrapyramidal system: a “short note” review -
H. Narabayashi, N. Yanagisawa, T. Nagatsu (1993)
Parkinson's Disease: From Basic Research to Treatment -
W. Horst, W. Pool, H. Spiegel (1973)
Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.European journal of pharmacology, 21 3
-
F. Kogan, W. Nichols, J. Gibb (1976)
Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels.European journal of pharmacology, 36 2
-
T. Obata, C. Chiueh (2005)
In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+Journal of Neural Transmission / General Section JNT, 89
-
H. Wachtel, M. Kunow, P. Löschmann (1992)
NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy- piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned ratsNeuroscience Letters, 142
-
L. Adams-Carr, BA Mbbs, Alastair Noyce (1985)
Predicting Parkinson's disease.Nature, 317 6034
-
(1988)
Human brain tyrosine hydroxylase: in vitro effects of iron and phosphorylating agents in the CNS of controls, Parkinson's disease and schizophrenia -
M. Starr (1995)
Antiparkinsonian actions of glutamate antagonists — alone and with L-DOPA: A review of evidence and suggestions for possible mechanismsJournal of Neural Transmission - Parkinson's Disease and Dementia Section, 10
-
G. Sengstock, C. Olanow, A. Dunn, G. Arendash (1992)
Iron induces degeneration of nigrostriatal neuronsBrain Research Bulletin, 28
-
M. Krueger, A. Tan, B. Ackrell, T. Singer (1993)
Is complex II involved in the inhibition of mitochondrial respiration by N-methyl-4-phenylpyridinium cation (MMP+) and N-methyl-beta-carbolines?The Biochemical journal, 291 ( Pt 3)
-
W Birkmayer, P Riederer (1975)
Responsibility of extrastriatal areas for the appearance of psychotic symptomsJ Neural Transm, 37
-
S. Hall, J. Rutledge, T. Schallert (1992)
MRI, brain iron and experimental Parkinson's diseaseJournal of the Neurological Sciences, 113
-
Hugo Monteiro, C. Winterbourn (1989)
6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation.Biochemical pharmacology, 38 23
-
T. Niwa, N. Takeda, N. Kaneda, Yoshio Hashizume, T. Nagatsu (1987)
Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains.Biochemical and biophysical research communications, 144 2
-
P Riederer, E Sofic, C Konradi (1986)
Spätsyndrome der Parkinson-Krankheit -
G. Alexander, D. Brainard, Sharon Gordon, M. Hichens, J. Grothusen, R. Schwartzman (1991)
Dopamine receptor changes in untreated and (+)-PHNO-treated MPTP parkinsonian primatesBrain Research, 547
-
R. Heikkila, P. Sonsalla (1992)
The MPTP-treated mouse as a model of Parkinsonism: How good is it?Neurochemistry International, 20
-
L. Zang, H. Misra (1992)
EPR kinetic studies of superoxide radicals generated during the autoxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium, a bioactivated intermediate of parkinsonian-inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.The Journal of biological chemistry, 267 33
-
H. Mochizuki, N. Nakamura, K. Nishi, Y. Mizuno (1994)
Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in ratNeuroscience Letters, 170
-
Z. Rossetti, A. Sotgiu, D. Sharp, Maria Hadjiconstantinou, N. Neff (1988)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro.Biochemical pharmacology, 37 23
-
S. Carboni, F. Melis, L. Pani, Maria Hadjiconstantinou, Z. Rossetti (1990)
The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+)Neuroscience Letters, 117
-
E. Neafsey, G. Drucker, K. Raikoff, M. Collins (1989)
Striatal dopaminergic toxicity following intranigral injection in rats of 2-methyl-norharman, a β-carbolinium analog of N-methyl-4-phenylpyridinium ion (MPP+)Neuroscience Letters, 105
-
T. Schallert, P. Teitelbaum (1981)
Haloperidol, catalepsy, and equilibrating functions in the rat: Antagonistic interaction of clinging and labyrinthine righting reactionsPhysiology & Behavior, 27
-
T. Abekawa, T. Ohmori, T. Koyama (1994)
Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbensBrain Research, 643
-
Y. Stern (1990)
MPTP-induced parkinsonismProgress in Neurobiology, 34
-
K. Lloyd, O. Hornykiewicz (1970)
Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain RegionsScience, 170
-
(1984)
Tetrahydroisoquinoline derivatives and Parkinsonism -
JL Cadet, P Sheng, S Ali, R Rothman, E Carlson, C Epstein (1994)
Attenuation of methamphetamine-induced neurotoxicity in copper/zinc Superoxide dismutase transgenic miceJ Neurochem, 62
-
M. During, Andrew Freese, A. Deutch, P. Kibat, R. Roth (1992)
Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomesExperimental Neurology, 115
-
W. Schmidt, M. Bubser, W. Hauber (1992)
Behavioural pharmacology of glutamate in the basal ganglia.Journal of neural transmission. Supplementum, 38
-
L. Turski, K. Bressler, K. Rettig, P. Löschmann, H. Wachtel (1991)
Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonistsNature, 349
-
H. Ehringer, O. Hornykiewicz (1960)
Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system.Parkinsonism & related disorders, 4 2
-
D. Berg, P. Riederer (1980)
Die Parkinson-Krankheit -
C. Harnois, Therese Paolof (1990)
Decreased dopamine in the retinas of patients with Parkinson's disease.Investigative ophthalmology & visual science, 31 11
-
B. Halliwell (1992)
Reactive Oxygen Species and the Central Nervous SystemJournal of Neurochemistry, 59
-
Raj Kumar, A. Agarwal, P. Seth (1995)
Free Radical‐Generated Neurotoxicity of 6‐HydroxydopamineJournal of Neurochemistry, 64
-
E. Sofić, P. Riederer, H. Heinsen, Helmut Beckmann, G. Reynolds, G. Hebenstreit, M. Youdim (2005)
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal of Neural Transmission, 74
-
R. Couture, D. Regoli (1982)
Mini review: smooth muscle pharmacology of substance P.Pharmacology, 24 1
-
B. Siesjö (1990)
Calcium in the brain under physiological and pathological conditions.European neurology, 30 Suppl 2
-
W. Maruyama, P. Dostert, M. Naoi (1995)
Dopamine‐Derived 1‐Methyl‐6,7‐Dihydroxyisoquinolines as Hydroxyl Radical Promoters and Scavengers in the Rat Brain: In Vivo and In Vitro StudiesJournal of Neurochemistry, 64
-
栄治 長谷川 (1993)
1-methyl-4-phenylpyridinium (MPP[+]) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles -
J. Fleagle (1975)
A small gibbon-like hominoid from the miocene of Uganda.Folia primatologica; international journal of primatology, 24 1
-
G. Ricaurte, J. Langston, L. Delanney, I. Irwin, S. Peroutka, L. Forno (1986)
Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessmentBrain Research, 376
-
S. Ohta, M. Kohno, Y. Makino, O. Tachikawa, M. Hirobe (1987)
TETRAHYDROISOQUINOLINE AND 1-METHYL-TETRAHYDROISOQUINOLINE ARE PRESENT IN THE HUMAN BRAIN: RELATION TO PARKINSON’S DISEASEBiomedical Research-tokyo, 8
-
G. Corsini, A. Zuddas, U. Bonuccelli, S. Schinelli, I. Kopin (1987)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by ethanol or acetaldehyde.Life sciences, 40 9
-
R. Moratalla, B. Quinn, L. Delanney, I. Irwin, Langston Jw, A. Graybiel (1992)
Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences of the United States of America, 89
-
M. Beal (1992)
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?Annals of Neurology, 31
-
C. Olanow (1993)
A radical hypothesis for neurodegenerationTrends in Neurosciences, 16
-
G. Davis, Adrian Williams, S. Markey, M. Ebert, E. Caine, Cheryl Reichert, I. Kopin (1979)
Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1
-
J. Parkinson (1969)
AN ESSAY ON THE SHAKING PALSYJAMA Neurology, 20
-
A. Kupsch, J. Sautter, J. Schwarz, P. Riederer, M. Gerlach, W. Oertel (1996)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal levelBrain Research, 741
-
L. Seiden, G. Vosmer (1984)
Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetaminePharmacology Biochemistry and Behavior, 21
-
S. O'dell, F. Weihmuller, J. Marshall (1991)
Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicityBrain Research, 564
-
P. Chan, D. Monte, Jin-jun Luo, L. Delanney, I. Irwin, J. Langston (1994)
Rapid ATP Loss Caused by Methamphetamine in the Mouse Striatum: Relationship Between Energy Impairment and Dopaminergic NeurotoxicityJournal of Neurochemistry, 62
-
Eiji Hasegawa, K. Takeshige, Tomonari Oishi, Yoshiyuki Murai, Shigeki Minakami (1990)
1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles.Biochemical and biophysical research communications, 170 3
-
P. Sonsalla, W. Nicklas, R. Heikkila (1989)
Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.Science, 243 4889
-
M. Lafon‐Cazal, S. Pietri, M. Culcasi, J. Bockaert (1993)
NMDA-dependent superoxide production and neurotoxicityNature, 364
-
T. Klockgether, L. Turski, T. Honoré, Zhiming Zhang, D. Gash, R. Kurlan, J. Greenamyre (1991)
The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine‐depleted rats and MPTP‐treated monkeysAnnals of Neurology, 30
-
J. Temlett, J. Landsberg, F. Watt, G. Orime (1994)
Increased Iron in the Substantia Nigra Compacta of the MPTP‐Lesioned Hemiparkinsonian African Green Monkey: Evidence from Proton Microprobe Elemental MicroanalysisJournal of Neurochemistry, 62
-
(1993)
Similarities and differences between MPTP-induced Parkinsonism and Parkinson's disease -
(1986)
Neurobiochemische Aspekte zur Progression der Parkinson-Krankheit: Post-mortem-Befunde und MPTP-Modell. In: Fischer PA (Hrsg) Spfitsyndrome der Parkinson-Krankheit -
A. Boireau, F. Bordier, P. Dubédat, A. Doble (1995)
Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmissionNeuroscience Letters, 195
-
(1994)
A marker of oxyradical-mediated DNA damage (8-hydroxy-2'deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain -
R. Sandyk, M. Brennan (1982)
Impairment of somatosensory feedback control of the tongue in Parkinson's disease: effect of L-Dopa therapy.The South African journal of communication disorders = Die Suid-Afrikaanse tydskrif vir Kommunikasieafwykings, 29
-
J. Cadet, Mindy Katz, V. Jackson-Lewis, S. Fahn (1989)
Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: Behavioral and biochemical evidenceBrain Research, 476
-
R. Heikkila, G. Cohen (1972)
Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine. Potentiation by ascorbic acid.Molecular pharmacology, 8 2
-
R. Albores, Edward NEAFSEYt, George DRUCKERt, Jeremy FIELDSt, M. Collins
Mitochondrial respiratory inhibition by N-methylated fi-carboline derivatives structurally resembling N-methyl-4-phenylpyridine -
C. Chiueh, S. Markey, R. Burns, J. Johannessen, D. Jacobowitz, I. Kopin (1984)
Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey.Psychopharmacology bulletin, 20 3
-
W. Maruyama, D. Nakahara, P. Dostert, Tsutomu Takahashi, M. Naoi (1995)
Dopamine-Derived Isoquinolines as Dopaminergic Neurotoxins and Oxidative Stress -
F. Weihmuller, Maria Hadjiconstantinou, J. Bruno (1989)
Dissociation between biochemical and behavioral recovery in MPTP-treated micePharmacology Biochemistry and Behavior, 34
-
A. Schapira (2004)
Evidence for mitochondrial dysfunction in Parkinson's disease—a critical appraisalMovement Disorders, 9
-
P. Hantraye, M. Varastet, M. Peschanski, D. Riche, P. Césaro, J. Willer, M. Maziére (1993)
Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboonsNeuroscience, 53
-
C Harnois, T Diapolo (1990)
Decreased dopamine in the retinas of patients with Parkinson's diseaseInvest Opthalmol Vis Sci, 31
-
K Jellinger (1988)
Handbook of experimental pharmacology, vol 88 -
Rausch Wd, M. Abdel-mohsen, Eleni Koutsilieri, W. Chan, Gerhard Bringmann (1995)
Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) in neuronal and glial cell cultures.Journal of neural transmission. Supplementum, 46
-
C. Pifl, G. Schingnitz, O. Hornykiewicz (1988)
The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's diseaseNeuroscience Letters, 92
-
A Kupsch, M Gerlach, SC Pupeter, J Sautter, A Dirr, G Arnold, W Opitz, H Przuntek, P Riederer, WH Oertel (1995)
The calcium channel blocker nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in miceNeuro-Report, 6
-
Verteilung Y0N, NOR-ADREqNALIN Und, Dopamin 3-HYDROXYTYRAMIN, IM Gehirn, Des Meschen, Und Yerhalten, Bei Erkrankungen, Des Extrapyramidalen, O. HoYKIWlCZ (2005)
Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen SystemsKlinische Wochenschrift, 38
-
G. Ricaurte, C. Schuster, L. Seiden (1980)
Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional studyBrain Research, 193
-
R. Heikkila, B. Sieber, L. Manzino, P. Sonsalla (1989)
Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.Molecular and chemical neuropathology, 10 3
-
K. Jellinger (1991)
Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.Molecular and chemical neuropathology, 14 3
-
W Wesemann, S Blaschke, H-W Clement, CHR Grote, N Weiner, W Kolasiewicz, KH Sontag (1993)
Iron in central nervous system disorders -
(1989)
Acute effects of 1methyl-4-phenylpyridinium -
A. Carlsson, M. Lindqvist, T. Magnusson (1957)
3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine AntagonistsNature, 180
-
D. Ben-Shachar, G. Eshel, J. Finberg, M. Youdim (1991)
The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine NeuronsJournal of Neurochemistry, 56
-
C. Grote, H. Clement, Wolfgang Wesemann, Gerhard Bringmann, D. Feineis, P. Riederer, Karl-Heinz Sontag (1995)
Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives.Journal of neural transmission. Supplementum, 46
-
W. Paulus, K. Jellinger (1991)
The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's DiseaseJournal of Neuropathology and Experimental Neurology, 50
-
A. Ueki, P. Chong, A. Albanese, S. Rose, J. Chivers, P. Jenner, C. Marsden (1989)
Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxinNeuropharmacology, 28
-
M. Naoi, W. Maruyama, P. Dostert, D. Nakahara, Tsutomu Takahashi, T. Nagatsu (1995)
Metabolic Bioactivation of Endogenous Isoquinolines as Dopaminergic Neurotoxins to Elicit Parkinson’s Disease -
W. Gibb, M. Terruli, A. Lees, P. Jenner, C. Marsden (1989)
The evolution and distribution of morphological changes in the nervous system of the common marmoset following the acute administration of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridineMovement Disorders, 4
-
S. Rose, Masahiro Nomoto, E.Amanda Jackson, William Gibb, Peter Jaehnig, Peter Jenner, C. Marsden (1993)
Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.European journal of pharmacology, 230 2
-
B. Sjöquist, A. Eriksson, B. Winblad (1982)
Salsolinol and catecholamines in human brain and their relation to alcoholism.Progress in clinical and biological research, 90
-
M Gerlach, K Jellinger, P Riederer (1994)
Noradrenergic mechanisms in Parkinson's disease -
W. Maruyama, D. Nakahara, M. Ota, Tsutomu Takahashi, A. Takahashi, T. Nagatsu, M. Naoi (1992)
N‐Methylation of Dopamine‐Derived 6,7‐Dihydroxy‐1,2,3,4‐Tetrahydroisoquinoline, (R)‐Salsolinol, in Rat Brains: In Vivo Microdialysis StudyJournal of Neurochemistry, 59
-
G. Bernocchi, G. Gerzeli, E. Scherini, C. Vignola (2004)
Neuroprotective effects of α-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,3,3,6-tetrahydropyridineActa Neuropathologica, 85
-
H. Thoenen, J. Tranzer (2004)
Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamineNaunyn-Schmiedebergs Archiv für Pharmakologie und experimentelle Pathologie, 261
-
K. Ikawa, A. Watanabe, N. Motohashi, S. Kaneno (1994)
The effect of repeated administration of methamphetamine on dopamine uptake sites in rat striatumNeuroscience Letters, 167
-
G. Smith, R. Young (1974)
A new experimental model of hypokinesia.Advances in neurology, 5
-
S. Barker, R. Harrison, J. Monti, G. Brown, S. Christian (1981)
Identification and quantification of 1,2,3,4-tetrahydro-β-carboline, 2-methyl-1,2,3,4-tetrahydro-β-carboline, and 6-methoxy-1,2,3,4-tetrahydro-β-carboline as in vivo constituents of rat brain and adrenal glandBiochemical Pharmacology, 30
-
S. Gilman, M. Bonner, T. Pellmar (1993)
Effect of oxidative stress on excitatory amino acid release by cerebral cortical synaptosomes.Free radical biology & medicine, 15 6
-
C. Pifl, G. Schingnitz, O. Hornykiewicz (1991)
Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkeyNeuroscience, 44
-
S. Goto, K. Korematsu, N. Inoue, Kazumichi Yamada, T. Oyama, S. Nagahiro, Y. Ushio (2004)
N-Methyl-d-aspartate receptor antagonist MK-801 induced circling behavior in rats with unilateral striatal ischemic lesions or nigral 6-hydroxydopamine lesionsActa Neuropathologica, 86
-
M. Zigmond, E. Stricker (1989)
Animal models of parkinsonism using selective neurotoxins: clinical and basic implications.International review of neurobiology, 31
-
M. Taylor, M. Ceballos, S. Rose, P. Chong, P. Jenner, C. Marsden (1991)
Neuropeptide levels in the basal ganglia of aged common marmosets following prolonged treatment with MPTPJournal of Neural Transmission - Parkinson's Disease and Dementia Section, 3
-
C. Colosimo, R. Granata, M. Zompo, M. Piccardi, G. Perretta, A. Albanese (1992)
Chronic administration of MPTP to monkeys: Behavioural morphological and biochemical correlatesNeurochemistry International, 20
-
G. Drucker, K. Raikoff, E. Neafsey, M. Collins (1990)
Dopamine uptake inhibitory capacities of β-carboline and 3,4-dihydro-β-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation productsBrain Research, 509
-
M. Morgan, J. Gibb (1980)
Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nucleiNeuropharmacology, 19
-
I. Irwin, K. Finnegan, L. Delanney, Donato Monte, J. Langston (1992)
The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessmentBrain Research, 572
-
J. Fields, R. Albores, E. Neafsey, M. Collins (1992)
Inhibition of mitochondrial succinate oxidation--similarities and differences between N-methylated beta-carbolines and MPP+.Archives of biochemistry and biophysics, 294 2
-
J. Gibb, F. Kogan (1979)
Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activityNaunyn-Schmiedeberg's Archives of Pharmacology, 310
-
S. Carmichael, R. Wilson, W. Brimijoin, L. Melton, H. Okazaki, T. Yaksh, J. Ahlskog, S. Stoddard, G. Tyce (1988)
Decreased catecholamines in the adrenal medulla of patients with parkinsonism.The New England journal of medicine, 318 4
-
R. Albores, E. Neafsey, G. Drucker, J. Fields, M. Collins (1990)
Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine.Proceedings of the National Academy of Sciences of the United States of America, 87
-
Y. Ichitani, H. Okamura, D. Nakahara, I. Nagatsu, Y. Ibata (1994)
Biochemical and Immunocytochemical Changes Induced by Intrastriatal 6-Hydroxydopamine Injection in the Rat Nigrostriatal Dopamine Neuron System: Evidence for Cell Death in the Substantia NigraExperimental Neurology, 130
-
T. Oishi, E. Hasegawa, Y. Murai (1993)
Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridime (MPTP) in the mouseJournal of Neural Transmission - Parkinson's Disease and Dementia Section, 6
-
P Riederer, S Wuketich (1976)
Time course of nigrostriatal degeneration in Parkinson's disease: a detailed study of influential factors in human brain amine analysisJ Neural Transm, 38
-
J. Adams, L. Klaidman, A. Leung (1993)
MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes.Free radical biology & medicine, 15 2
-
E. Fazzini, E. Fazzini, Raymon Durso, Raymon Durso, H. Davoudi, H. Davoudi, G. Szabo, G. Szabo, M. Albert, M. Albert (1990)
GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in miceJournal of the Neurological Sciences, 99
-
Ce Lambert, Bondy, Sc
Previously Published Works Uc Irvine Title: Effects of Mptp, Mpp+ and Paraquat on Mitochondrial Potential and Oxidative Stress -
CE Lambert, SC Bondy (1989)
Effects of MPTP, MPP+ and paraquat on mitochondrial potential and oxidative stressLife Sci, 44
-
G. Sengstock, C. Olanow, R. Menzies, A. Dunn, G. Arendash (1993)
Infusion of iron into the rat substantia nigra: Nigral pathology and dose‐dependent loss of striatal dopaminergic markersJournal of Neuroscience Research, 35
-
I. Mitchell, A. Cross, M. Sambrook, A. Crossman (1985)
Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleusNeuroscience Letters, 61
-
M Naoi, W Maruyama, P Dostert, D Nakahara, T Takahashi, T Nagatsu (1995)
Alzheimer's and Parkinson's disease -
E. Oestreicher, G. Sengstock, P. Riederer, C. Olanow, A. Dunn, G. Arendash (1994)
Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical studyBrain Research, 660
-
P. Sonsalla, G. Zeevalk, L. Manzino, A. Giovanni, W. Nicklas (1992)
MK‐801 Fails to Protect Against the Dopaminergic Neuropathology Produced by Systemic 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mice or Intranigral 1‐Methyl‐4‐Phenylpyridinium in RatsJournal of Neurochemistry, 58
-
D. Reynolds, N. Garrett (2005)
Striatal dopamine and homovanillic acid in Huntington's DiseaseJournal of Neural Transmission, 65
-
(1993)
Effects of nimodipine on the 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP)-induced depletions on the biogenic amine levels in C57BL/6-mice -
G. Corsini, S. Pintus, C. Chiueh, J. Weiss, I. Kopin (1985)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.European journal of pharmacology, 119 1-2
-
T. Zetterström, T. Sharp, A. Collin, Urban Ungerstedt (1988)
In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC.European journal of pharmacology, 148 3
-
K. Sontag, C. Heim, T. Sontag, R. God, H. Reichmann, W. Wesemann, W. Rausch, P. Riederer, G. Bringmann (1995)
Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) after subchronic treatment in rats.Journal of neural transmission. Supplementum, 46
-
Christopher Schmidt, J. Ritter, P. Sonsalla, G. Hanson, J. Gibb (1985)
Role of dopamine in the neurotoxic effects of methamphetamine.The Journal of pharmacology and experimental therapeutics, 233 3
-
P. Bédard, R. Boucher (1989)
Effect of D1 receptor stimulation in normal and MPTP monkeysNeuroscience Letters, 104
-
H. Przuntek, H. Russ, K. Henning, U. Pindur (1985)
The protective effect of 1-tert.butyl-4,4-diphenylpiperidine against the nigrostriatal neurodegeneration caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Life sciences, 37 13
-
Hansen Van, Zandt Law, W. Briles, Longen-Ecker Pazderka, J. Gavora, R Spencer, Ruth, W Brilei, R Stone, Science, W Droege, Miggieno Hala, Ziegler, D. Ewert, W Gilmour, M Vilhelmovb, J Maggiano, K. Pink, J Hkla, Eiiv Hartmanovi, M Simonsen, In Hkla, A. Benedict, Plenum, I. Doherty, R. Zinkernagle (1983)
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.Science, 219 4587
-
Charlotte Sachs, Gösta Jonsson (1975)
Mechanisms of action of 6-hydroxydopamine.Biochemical pharmacology, 24 1
-
K. Tipton, T. Singer (1993)
Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related CompoundsJournal of Neurochemistry, 61
-
P. Riederer, E. Sofić, G. Heuschneider, M. Benedetti, P. Dostert (1988)
Secondary (toxic) parkinsonism as model of Parkinson's disease.Functional neurology, 3 4
-
E. Hodgson, I. Fridovich (1975)
The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme.Biochemistry, 14 24
-
C. Tanner (1989)
The role of environmental toxins in the etiology of Parkinson's diseaseTrends in Neurosciences, 12
-
E. Sundström, A. Fredriksson, T. Archer (1990)
Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's diseaseBrain Research, 528
-
S. Snyder, R. D'Amato (1985)
Neurology: Predicting Parkinson's diseaseNature, 317
-
A. Zuddas, F. Vaglini, F. Fornai, G. Corsini (1992)
Selective lesion of the nigrostriatal dopaminergic pathway by MPTP and acetaldehydehyde or diethyldithiocarbamateNeurochemistry International, 20
-
I. Date, D. Felten, S. Felten (1990)
Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysisBrain Research, 519
-
I. Jurna, T. Nell, I. Schreyer (2005)
Motor disturbance induced by tremorine and oxotremorineNaunyn-Schmiedebergs Archiv für Pharmakologie, 267
-
S. Przedborski, V. Jackson-Lewis, U. Muthane, Hong Jiang, Mayra Ferreira, A. Naini, S. Fahn (1993)
Chronic levodopa administration alters cerebral mitochondrial respiratory chain activityAnnals of Neurology, 34
-
Ambani Lm, Van Mh, S. Murphy (1975)
Brain peroxidase and catalase in Parkinson disease.Archives of neurology, 32 2
-
M. Naoi, W. Maruyama, Toshimitsu Niwa, Toshiharu Nagatsu (1994)
Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin.Journal of neural transmission. Supplementum, 41
-
H Ehringer, O Hornykiewicz (1960)
Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen SystemsWien Klin Wochenschr, 38
-
M. Gerlach, P. Riederer (1993)
The Pathophysiological Basis of Parkinson’s Disease -
J. Baik, R. Picetti, A. Saiardi, G. Thiriet, A. Dierich, A. Depaulis, M. Meur, E. Borrelli (1995)
Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptorsNature, 377
-
Arthur Perumal, V. Gopal, W. Tordzro, Thomas Cooper, Jean Cadet (1992)
Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brainBrain Research Bulletin, 29
-
G. Breese, AimT, Dennis Traylor (1970)
Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.The Journal of pharmacology and experimental therapeutics, 174 3
-
A. Kupsch, P. Löschmann, H. Sauer, G. Arnold, Petra Renner, D. Pufal, M. Burg, H. Wachtel, G. Bruggencate, W. Oertel (1992)
Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black miceBrain Research, 592
-
W Maruyama, D Nakahara, P Dostert, T Takahashi, M Naoi (1995)
Alzheimer's and Parkinson's disease. Recent developments -
K. Jellinger, L. Linert, E. Kienzl, E. Herlinger, M. Youdim (1995)
Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's disease.Journal of neural transmission. Supplementum, 46
-
C. Altar, R. Heikkila, L. Manzino, M. Marien (1986)
1-Methyl-4-phenylpyridine (MPP+): regional dopamine neuron uptake, toxicity, and novel rotational behavior following dopamine receptor proliferation.European journal of pharmacology, 131 2-3
-
S. Rose, M. Nomoto, E. Jackson, W. Gibb, P. Jenner, C. Marsden (1990)
1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) is less neurotoxic than MPTP in the common marmoset.European journal of pharmacology, 181 1-2
-
I. Pérez-Otan˜o, M. Herrero, C. Oset, M. Ceballos, M. Luquin, J. Obeso, J. Rı́o (1991)
Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmosetBrain Research, 567
-
G. Horst, M. Knigge, A. Wal (1992)
Neurochemical lesioning in the rat brain with iontophoretic injection of the 1-methyl-4-phenylpyridinium ion (MPP+)Neuroscience Letters, 141
-
B. Testa, R. Naylor, B. Costall, P. Jenner, C. Marsden (1985)
Does an endogenous methylpyridinium analogue cause Parkinson's disease?Journal of Pharmacy and Pharmacology, 37
-
M Gerlach, P Riederer, MBH Youdim (1996)
Advances in neurology, vol 69 -
Heinz Reichmann, Patrick Lestienne, K. Jellinger, P. Riederer (1993)
Parkinson's disease and the electron transport chain in postmortem brain.Advances in neurology, 60
-
B. Gomez-Mancilla, R. Boucher, P. Bédard (1991)
Effect of clonidine and atropine on rest tremor in the MPTP monkey model of parkinsonism.Clinical neuropharmacology, 14 4
-
I. Jurna, W. Grossmann, T. Nell (1973)
Depression by amantadine of tremor induced by reserpine and oxotremorine in the ratNaunyn-Schmiedeberg's Archives of Pharmacology, 280
-
W Birkmayer, P Riederer (1985)
Die Parkinson-Krankheit: Biochemie, Klinik, Therapie -
J. Turrens, A. Boveris (1980)
Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria.The Biochemical journal, 191 2
-
J. Sullivan, K. Tipton (1992)
Interactions of the neurotoxin MPTP and its demethylated derivative (PTP) with monoamine oxidase-BNeurochemical Research, 17
-
U. Ungerstedt (1968)
6-Hydroxy-dopamine induced degeneration of central monoamine neurons.European journal of pharmacology, 5 1
-
M Gerlach, P Riederer (1993)
Inhibitors of monoamine oxidase B -
Tsutomu Takahashi, Yulin Deng, W. Maruyama, P. Dostert, M. Kawai, M. Naoi (2005)
Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport systemJournal of Neural Transmission / General Section JNT, 98
-
(1978)
Pharmakologische Modelle zur Wirkung von Antiparkinsonmitteln -
Floyd Bloom, S. Algeri, A. Groppetti, A. Revuelta, E. Costa (1969)
Lesions of Central Norepinephrine Terminals with 6-OH-Dopamine: Biochemistry and Fine StructureScience, 166
-
P. Mcgeer, Sir Eccles, E. Mcgeer (1978)
Molecular Neurobiology of the Mammalian Brain -
G. Arendash, C. Olanow, G. Sengstock (1993)
Intranigral iron infusion in rats: A progressive model for excess nigral iron levels in Parkinson’s disease? -
J. Cadet, P. Sheng, S. All, R. Rothman, E. Carlson, C. Epstein (1994)
Rapid Communication: Attenuation of Methamphetamine‐Induced Neurotoxicity in Copper/Zinc Superoxide Dismutase Transgenic MiceJournal of Neurochemistry, 62
-
I. Irwin, J. Langston, L. Delanney (1987)
4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.Life sciences, 40 8
-
J. Nash, B. Yamamoto (1992)
Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3, 4-methylenedioxymethamphetamineBrain Research, 581
-
E. Nwanze, F. Souverbie, G. Jonsson, E. Sundström (1995)
Regional biotransformation of MPTP in the CNS of rodents and its relation to neurotoxicity.Neurotoxicology, 16 3
-
M. Ballarín, J. Reiriz, S. Ambrosio, M. Camps, R. Blesa, N. Mahy (1989)
Acute effects of 1-methyl-1,4-phenylpyridinium ion (MPP+) on purine metabolism in rat striatum studied in vivo using the microdialysis techniqueBrain Research, 483
-
JR Boissier, P Simon (1963)
Un test simple pour l'étude quantitative de la catatonie provoquée chez le rat par les neuroleptiques. Application a l'étude des anticatatoniquesThérapie, 18
-
M. Santiago, L. Granero, A. Machado, J. Cano (1995)
Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.European journal of pharmacology, 280 3
-
M. Naoi, W. Maruyama, P. Dostert, Y. Hashizume, D. Nakahara, Tsutomu Takahashi, M. Ota (1996)
Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studiesBrain Research, 709
-
N. Seniuk, W. Tatton, Carol Greenwood (1990)
Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTPBrain Research, 527
-
(1963)
Un test simple pour l'6tude quantitative de la catatonie provoqude chez le rat par les neuroleptiques -
E. Sofić, K. Lange, K. Jellinger, P. Riederer (1992)
Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's diseaseNeuroscience Letters, 142
-
H. Russ, W. Mihatsch, M. Gerlach, P. Riederer, H. Przuntek (1991)
Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: Implications for Parkinson's disease?Neuroscience Letters, 123
-
P. Dostert, M. Benedetti, G. Dordain (2005)
Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseasesJournal of Neural Transmission, 74
-
WRG Gibb, JM Fearnley, AJ Lees (1990)
Parkinson's disease. Anatomy, pathology, and therapy -
R. Smith, Zheng Zhang, R. Kurlan, Michael McDermott, Don Gash (1993)
Developing a stable bilateral model of parkinsonism in rhesus monkeysNeuroscience, 52
-
D. Ben-Shachar, M. Youdim (1991)
Intranigral Iron Injection Induces Behavioral and Biochemical “Parkinsonism” in RatsJournal of Neurochemistry, 57
-
Wolfgang Hauber (1990)
A novel reaction time task for investigating force and time parameters of locomotor initiation in ratsExperientia, 46
-
G. Wagner, L. Seiden, C. Schuster (1979)
Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs.Drug and alcohol dependence, 4 5
-
K. Mizukawa, E. Mcgeer, P. Mcgeer (1993)
Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, Alzheimer disease, and neurologically normal controls.Molecular and chemical neuropathology, 18 1-2
-
J. Elsworth, Ariel Deutch, D. Redmond, Jane Taylor, J. Sladek, R. Roth (1989)
Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regionsNeuroscience, 33
-
R. Heikkila, W. Nicklas, I. Vyas, R. Duvoisin (1985)
Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: Implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicityNeuroscience Letters, 62
-
K. Lloyd, L. Davidson, O. Hornykiewicz (1975)
The neurochemistry of Parkinson's disease: effect of L-dopa therapy.The Journal of pharmacology and experimental therapeutics, 195 3
-
M. Ryck, T. Schallert, P. Teitelbaum (1980)
Morphine versus haloperidol catalepsy in the rat: A behavioral analysis of postural support mechanismsBrain Research, 201
-
M. Desole, G. Esposito, L. Fresu, R. Migheli, P. Enrico, M. Miele, G. Natale, E. Miele (1993)
Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3-6-tetrahydropyridine (MPTP)-treated ratNeuroscience Letters, 161
-
E. Storey, B. Hyman, B. Jenkins, E. Brouillet, Joanne Miller, Bruce Rosen, M. Beal (1992)
1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative MetabolismJournal of Neurochemistry, 58
-
F. Karoum, S. Chrapusta, M. Egan, R. Wyatt (1993)
Absence of 6‐Hydroxydopamine in the Rat Brain After Treatment with Stimulants and Other Dopaminergic Agents: A Mass Fragmentographic StudyJournal of Neurochemistry, 61
-
H. Miller, P. Shore, D. Clarke (1980)
In vivo monoamine oxidase inhibition by d-amphetamine.Biochemical pharmacology, 29 10
-
PL McGeer, JC Eccles, EG McGeer (1987)
Neuroleptics -
Nils-Erik Andén, Annica Dahlström, K. Fuxe, Knut Larsson (2009)
Functional role of the nigro-neostriatal dopamine neurons.Acta pharmacologica et toxicologica, 24 2
-
W. Danysz, M. Gossel, W. Zajaczkowski, D. Dill, G. Quack (1994)
Are NMDA antagonistic properties relevant for antiparkinsonianlike activity in rats?—Case of amantadine and memantineJournal of Neural Transmission - Parkinson's Disease and Dementia Section, 7
-
P Riederer, E Sofic, WD Rausch, G Hebenstreit, J Bruinvels (1989)
Early diagnosis and preventive therapy in Parkinson's disease -
J. Schulz, D. Henshaw, R. Matthews, M. Beal (1995)
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicityExperimental Neurology, 132
-
A. Hartley, James Stone, C. Heron, J. Cooper, A. Schapira (1994)
Complex I Inhibitors Induce Dose‐Dependent Apoptosis in PC12 Cells: Relevance to Parkinson's DiseaseJournal of Neurochemistry, 63
-
W. Gibb, J. Fearnley, A. Lees (1990)
The anatomy and pigmentation of the human substantia nigra in relation to selective neuronal vulnerability.Advances in neurology, 53
-
Dijrte Otto, K. Unsicker (1990)
Basic FGF reverses chemical and morphological deficits in the nigrostriatal system of MPTP-treated mice, 10
-
A. Crossman, D. Peggs, S. Boyce, M. Luquin, M. Sambrook (1989)
Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkeyNeuropharmacology, 28
-
K. Mithöfer, M. Sandy, M. Smith, D. Monte (1992)
Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes.Archives of biochemistry and biophysics, 295 1
-
W. Birkmayer, P. Riederer (2005)
Responsibility of extrastriatal areas for the appearance of psychotic symptoms (Clinical and biochemical human post-mortem findings)Journal of Neural Transmission, 37
-
R. Butterworth, F. Bélanger, A. Barbeau (1978)
Hypokinesia produced by anterolateral hypothalamic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugsPharmacology Biochemistry and Behavior, 8
-
W. Mihatsch, H. Russ, M. Gerlach, P. Riederer, H. Przuntek (1991)
Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: Preliminary observationsJournal of Neural Transmission - Parkinson's Disease and Dementia Section, 3
-
S. Kish, Caryl Morito, O. Hornykiewicz (1985)
Glutathione peroxidase activity in Parkinson's disease brainNeuroscience Letters, 58
-
Manfred Gerlach, P. Riederer, Mbh Youdim (1996)
Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acids.Advances in neurology, 69
-
P. Gaspar, A. Febvret, J. Colombo (1993)
Serotonergic sprouting in primate MTP-induced hemiparkinsonismExperimental Brain Research, 96
-
L. Seiden, M. Fischman, C. Schuster (1976)
Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys.Drug and alcohol dependence, 1 3
-
K. Jellinger (1989)
Pathology of Parkinson’s Syndrome -
N. Riachi, S. Harik (1988)
Strain differences in systematic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrierLife Sciences, 42
-
N. Uretsky, L. Iversen (1970)
EFFECTS OF 6‐HYDROXYDOPAMINE ON CATECHOLAMINE CONTAINING NEURONES IN THE RAT BRAINJournal of Neurochemistry, 17
-
J. Schulz, R. Matthews, M. Muqit, S. Browne, M. Beal (1995)
Inhibition of Neuronal Nitric Oxide Synthase by 7‐Nitroindazole Protects Against MPTP‐Induced Neurotoxicity in MiceJournal of Neurochemistry, 64
-
K. Lange, P. Löschmann, E. Sofić, M. Burg, R. Horowski, K. Kalveram, H. Wachtel, P. Riederer (1993)
The competitive NMDA antagonist CPP protects substantia nigra neurons from MPTP-induced degeneration in primatesNaunyn-Schmiedeberg's Archives of Pharmacology, 348
-
S. Close, P. Elliott, A. Hayes, A. Marriott (2005)
Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's diseasePsychopharmacology, 102
-
N. Riachi, S. Harik (1988)
Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier.Life sciences, 42 23
-
L. Buja, M. Eigenbrodt, E. Eigenbrodt (1993)
Apoptosis and necrosis. Basic types and mechanisms of cell death.Archives of pathology & laboratory medicine, 117 12
-
P. Michel, S. Vyas, Y. Agid (1992)
Toxic Effects of Iron for Cultured Mesencephalic Dopaminergic Neurons Derived from Rat Embryonic BrainsJournal of Neurochemistry, 59
-
W. Rausch, Y. Hirata, T. Nagatsu, P. Riederer, K. Jellinger (1988)
Tyrosine Hydroxylase Activity in Caudate Nucleus from Parkinson's Disease: Effects of Iron and Phosphorylating AgentsJournal of Neurochemistry, 50
-
H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, F. Seitelberger (1973)
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.Journal of the neurological sciences, 20 4
-
C. Porter, J. Totaro, C. Stone (1963)
Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice.The Journal of pharmacology and experimental therapeutics, 140
-
D. Vaux (1993)
Toward an understanding of the molecular mechanisms of physiological cell death.Proceedings of the National Academy of Sciences of the United States of America, 90
-
D. Dexter, C. Carter, F. Wells, F. Javoy‐Agid, Y. Agid, A. Lees, P. Jenner, C. Marsden (1989)
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's DiseaseJournal of Neurochemistry, 52
-
B. Dipasquale, Ann Marini, R. Youle (1991)
Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons.Biochemical and biophysical research communications, 181 3
-
Y. Wang, M. Hamburger, C. Cheng, B. Costall, R. Naylor, P. Jenner, K. Hostettmann (1991)
Neurotoxic Sesquiterpenoids from the Yellow Star Thistle Centaurea solstitialis L. (Asteraceae)Helvetica Chimica Acta, 74
-
M. Vito, G. Wagner (1989)
Methamphetamine-induced neuronal damage: A possible role for free radicalsNeuropharmacology, 28
-
(1993)
Neural Transm [PD-Sect -
M. Gerlach, M. Götz, A. Dirr, A. Kupsch, B. Janetzky, W. Oertel, J. Sautter, J. Schwarz, H. Reichmann, P. Riederer (1996)
Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxinNeurochemistry International, 28
-
M. Cleeter, J. Cooper, A. Schapira (1992)
Irreversible Inhibition of Mitochondrial Complex I by 1‐Methyl‐4‐Phenylpyridinium: Evidence for Free Radical InvolvementJournal of Neurochemistry, 58
-
C. Ríos, R. Tapia (1987)
Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenatesNeuroscience Letters, 77
-
G. Wagner, G. Ricaurte, L. Seiden, C. Schuster, Richard Miller, J. Westley (1980)
Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamineBrain Research, 181
-
Yelena Glinka, Moussa Youdim (1995)
Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine.European journal of pharmacology, 292 3-4
-
M. Collins, E. Neafsey (1985)
β-Carboline analogues of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP): Endogenous factors underlying idiopathic parkinsonism?Neuroscience Letters, 55
-
J. Marshall, S. O'dell, F. Weihmuller (2005)
Dopamine-glutamate interactions in methamphetaminc-induced neurotoxicityJournal of Neural Transmission / General Section JNT, 91
-
P. Riederer, E. Sofić, W. Rausch, B. Schmidt, G. Reynolds, K. Jellinger, M. Youdim (1989)
Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian BrainsJournal of Neurochemistry, 52
-
U. Ungerstedt, G. Arbuthnott (1970)
Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.Brain research, 24 3
-
M. Mavridis, A. Degryse, A. Lategan, M. Marien, F. Colpaert (1991)
Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: A possible role for the locus coeruleus in the progression of Parkinson's diseaseNeuroscience, 41
-
T. Ohmori, T. Koyama, A. Muraki, I. Yamashita (2005)
Competitive and noncompetitive N-methyl-D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regionsJournal of Neural Transmission / General Section JNT, 92
-
T. Kita, George Wagner, M. Philbert, Linda King, Herbert Lowndes (1995)
Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion.Molecular and chemical neuropathology, 24 1
-
P. Sonsalla, D. Riordan, R. Heikkila (1991)
Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice.The Journal of pharmacology and experimental therapeutics, 256 2
-
A. Espino, B. Cutillas, A. Tortosa, I. Ferrer, R. Bartrons, S. Ambrosio (1995)
Chronic effects of single intrastriatal injections of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium studied by microdialysis in freely moving ratsBrain Research, 695
-
Andreas Kupsch, Manfred Gerlach, Sigrid Pupeter, J. Sautter, Albrecht Dirr, Guy Arnold, Wolfgang Opitz, Horst Przuntek, Peter Riederer, Wolfgang Oertel (1995)
Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice.Neuroreport, 6 4
-
M. Carlsson, A. Carlsson (1989)
Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidineJournal of Neural Transmission - Parkinson's Disease and Dementia Section, 1
-
R. Fog (1972)
On stereotypy and catalepsy: studies on the effect of amphetamines and neuroleptics in rats.Acta neurologica Scandinavica. Supplementum, 50
-
Gerhard Bringmann, R. God, D. Feineis, Wolfgang Wesemann, P. Riederer, Wolf-Dieter Rausch, Heinz Reichmann, Karl-Heinz Sontag (1995)
The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons.Journal of neural transmission. Supplementum, 46
-
T. Bates, S. Heales, S. Davies, P. Boakye, J. Clark (1994)
Effects of 1‐Methyl‐4‐Phenylpyridinium on Isolated Rat Brain Mitochondria: Evidence for a Primary Involvement of Energy DepletionJournal of Neurochemistry, 63
-
M. Gerlach, M. Gerlach, P. Riederer, H. Przuntek, M. Youdim (1991)
MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.European journal of pharmacology, 208 4
-
G. Sengstock, C. Olanow, A. Dunn, S. Barone, G. Arendash (1994)
Progressive Changes in Striatal Dopaminergic Markers, Nigral Volume, and Rotational Behavior Following Iron Infusion into the Rat Substantia NigraExperimental Neurology, 130
-
J. Knoll (1986)
The pharmacology of (-)deprenyl.Journal of neural transmission. Supplementum, 22
-
JL Cadet, M Katz, V Jackson-Lewis, S Fahn (1989)
Vitamin E attenuates the toxic effects of intrastriatal injection of 6-OHDA in rats: behavioral and biochemical evidenceBrain Res, 476
-
P. Riederer, W. Rausch, W. Birkmayer, K. Jellinger, D. Seemann (1978)
CNS Modulation of adrenal tyrosine hydroxylase in Parkinson's disease and metabolic encephalopathies.Journal of neural transmission. Supplementum, 14
-
D. German, M. Dubach, S. Askari, S. Speciale, D. Bowden (1988)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonian syndrome in Macaca fascicularis: Which midbrain dopaminergic neurons are lost?Neuroscience, 24
-
F. Colpaert (1987)
Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in ratNeuropharmacology, 26
-
(1985)
Neurochemical and behavioral consequences following MPTP administration -
P. Sanberg, M. Bunsey, M. Giordano, A. Norman (1988)
The catalepsy test: its ups and downs.Behavioral neuroscience, 102 5
-
G. Everett (1956)
Tremor produced by DrugsNature, 177
-
M. Luquin, J. Obeso, J. Laguna, J. Guillén, J. Martínez-Lage (1993)
The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys.European journal of pharmacology, 235 2-3
-
C. Pifl, O. Bertel, G. Schingnitz, O. Hornykiewicz (1990)
Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Neurochemistry International, 17
-
H. Saggu, J. Cooksey, D. Dexter, F. Wells, A. Lees, P. Jenner, C. Marsden (1989)
A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia NigraJournal of Neurochemistry, 53
-
W Hauber (1990)
A novel reaction time task for investigating force and time parameters in ratsExperientia, 46
-
Burns Rs, C. Chiueh, S. Markey, M. Ebert, D. Jacobowitz, I. Kopin (1983)
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences of the United States of America, 80 14
-
丸山 和佳子 (1993)
N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains : in vivo microdialysis study -
P. Löschmann, K. Lange, M. Kunow, K. Rettig, P. Jähnig, T. Honoré, L. Turski, H. Wachtel, P. Jenner, C. Marsden (1991)
Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's diseaseJournal of Neural Transmission - Parkinson's Disease and Dementia Section, 3
-
U. Wüllner, A. Kupsch, G. Arnold, P. Renner, C. Scheid, R. Scheid, W. Oertel, T. Klockgether (1992)
The competitive NMDA antagonist CGP40.116 enhances L-DOPA response in MPTP-treated marmosetsNeuropharmacology, 31
-
H. Braak, E. Braak, D. Yilmazer, C. Schultz, de Ra, J. En (1995)
Nigral and extranigral pathology in Parkinson's disease.Journal of neural transmission. Supplementum, 46
-
B. McMillen (1983)
CNS stimulants: two distinct mechanisms of action for amphetamine-like drugsTrends in Pharmacological Sciences, 4
-
I. Irwin, L. Delanney, L. Forno, K. Finnegan, D. Monte, J. Langston (1990)
The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkeyBrain Research, 531
-
F. Hefti, E. Melamed, B. Sahakian, R. Wurtman (1980)
Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPAPharmacology Biochemistry and Behavior, 12
-
Wolfgang Wesemann, S. Blaschke, M. Solbach, C. Grote, H. Clement, P. Riederer (1994)
Intranigral injected iron progressively reduces striatal dopamine metabolismJournal of Neural Transmission - Parkinson's Disease and Dementia Section, 8
-
Y. Deng, W. Maruyama, P. Dostert, T. Takahashi, M. Kawai, M. Naoi (1995)
Determination of the (R)- and (S)-enantiomers of salsolinol and N-methylsalsolinol by use of a chiral high-performance liquid chromatographic column.Journal of chromatography. B, Biomedical applications, 670 1
-
V. Jackson-Lewis, M. Jakowec, R. Burke, S. Przedborski (1995)
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration, 4 3
-
M. Marien, M. Briley, F. Colpaert (1993)
Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice.European journal of pharmacology, 236 3
-
W. Gibb (1989)
The diagnostic relevance of Lewy bodies and other inclusions in Parkinson’s disease -
W. Wesemann, S. Blaschke, H. Clement, C. Grote, N. Weiner, W. Kolasiewicz, K. Sontag (1993)
Iron and neurotoxin intoxication: comparative in vitro and in vivo studies
- Publisher
- Springer Journals
- Copyright
- Copyright © 1996 by Springer-Verlag
- Subject
- Medicine & Public Health; Neurology; Psychiatry; Neurosciences
- ISSN
- 0300-9564
- eISSN
- 1435-1463
- DOI
- 10.1007/BF01291788
- Publisher site
- See Article on Publisher Site
Abstract
Animal models are an important aid in experimental medical science because they enable one to study the pathogenetic mechanisms and the therapeutic principles of treating the functional disturbances (symptoms) of human diseases. Once the causative mechanism is understood, animal models are also helpful in the development of therapeutic approaches exploiting this understanding. On the basis of experimental and clinical findings. Parkinson's disease (PD) became the first neurological disease to be treated palliatively by neurotransmitter replacement therapy.
Journal
Journal of Neural Transmission – Springer Journals
Published: Feb 24, 2005